Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1282

1.

Dofetilide reduces the frequency of ventricular arrhythmias and implantable cardioverter defibrillator therapies.

Baquero GA, Banchs JE, Depalma S, Young SK, Penny-Peterson ED, Samii SM, Wolbrette DL, Naccarelli GV, Gonzalez MD.

J Cardiovasc Electrophysiol. 2012 Mar;23(3):296-301. doi: 10.1111/j.1540-8167.2011.02183.x. Epub 2011 Sep 28.

PMID:
21955243
2.

Radiofrequency catheter ablation of sustained ventricular tachycardia in idiopathic dilated cardiomyopathy.

Kottkamp H, Hindricks G, Chen X, Brunn J, Willems S, Haverkamp W, Block M, Breithardt G, Borggrefe M.

Circulation. 1995 Sep 1;92(5):1159-68.

3.

Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention.

Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M.

Clin Cardiol. 2011 Oct;34(10):604-9. doi: 10.1002/clc.20949. Epub 2011 Sep 1.

4.

Postoperative ventricular arrhythmias after cardiac surgery: immediate- and long-term significance.

Brembilla-Perrot B, Villemot JP, Carteaux JP, Haouzi A, Amrein D, Schöth B, Houriez P, Beurrier D, Djaballah K, Vançon AC, Nippert M.

Pacing Clin Electrophysiol. 2003 Feb;26(2 Pt 1):619-25.

PMID:
12710323
6.

Survival after cardiac arrest or sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy.

Elliott PM, Sharma S, Varnava A, Poloniecki J, Rowland E, McKenna WJ.

J Am Coll Cardiol. 1999 May;33(6):1596-601.

7.
8.

Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.

Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.

G Ital Cardiol. 1999 Oct;29(10):1142-56.

PMID:
10546124
9.

Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.

Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.

J Am Coll Cardiol. 1999 Jan;33(1):46-52.

10.

Long-term follow-up in patients with arrhythmogenic right ventricular cardiomyopathy.

Li CH, Lin YJ, Huang JL, Wu TJ, Cheng CC, Lin WS, Tuan TC, Chang SL, Lo LW, Hu YF, Chao TF, Chung FP, Tsai CF, Tsao HM, Chen SA.

J Cardiovasc Electrophysiol. 2012 Jul;23(7):750-6. doi: 10.1111/j.1540-8167.2011.02288.x. Epub 2012 Feb 21.

PMID:
22353378
11.

[Short-term and long-term outcome of left heart function after cardioverter defibrillator implantation].

Takeichi K, Kasanuki H, Ohnishi S, Endoh Y, Hosoda S.

J Cardiol. 1996 Nov;28(5):277-86. Japanese.

PMID:
8953401
12.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
13.

Efficacy of automatic multimodal device therapy for ventricular tachyarrhythmias as delivered by a new implantable pacing cardioverter-defibrillator. Results of a European multicenter study of 102 implants.

Fromer M, Brachmann J, Block M, Siebels J, Hoffmann E, Almendral J, Ohm OJ, den Dulk K, Coumel P, Camm AJ, et al.

Circulation. 1992 Aug;86(2):363-74.

PMID:
1638705
14.

Sudden death in implantable cardioverter-defibrillator recipients: clinical context, arrhythmic events and device responses.

Pires LA, Lehmann MH, Steinman RT, Baga JJ, Schuger CD.

J Am Coll Cardiol. 1999 Jan;33(1):24-32.

15.

Comparison of arrhythmia recurrence in patients presenting with ventricular fibrillation versus ventricular tachycardia in the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.

Raitt MH, Klein RC, Wyse DG, Wilkoff BL, Beckman K, Epstein AE, Coromilas J, Friedman PL, Martins J, Ledingham RB, Greene HL; Antiarrhythmics Versus Implantable Defibrillators Investigators.

Am J Cardiol. 2003 Apr 1;91(7):812-6.

PMID:
12667566
16.

Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.

Bunch TJ, Mahapatra S, Murdock D, Molden J, Weiss JP, May HT, Bair TL, Mader KM, Crandall BG, Day JD, Osborn JS, Muhlestein JB, Lappe DL, Anderson JL.

Pacing Clin Electrophysiol. 2011 Dec;34(12):1600-6. doi: 10.1111/j.1540-8159.2011.03208.x. Epub 2011 Sep 3.

PMID:
21895727
17.

Role of antiarrhythmic therapy in patients at risk for sudden cardiac death: an evidence-based review.

Hilleman DE, Bauman AL.

Pharmacotherapy. 2001 May;21(5):556-75. Review.

PMID:
11349745
18.

Left ventricular ejection fraction and absence of ACE inhibitor/angiotensin II receptor blocker predicts appropriate defibrillator therapy in the primary prevention population.

Obeyesekere MN, Chan W, Stub D, Prabhu S, Teo EP, Toogood G, Mariani J, Broughton A, Kistler PM.

Pacing Clin Electrophysiol. 2010 Jun 1;33(6):696-704. doi: 10.1111/j.1540-8159.2009.02669.x. Epub 2010 Jan 5.

PMID:
20059719
19.

Clinical and electrophysiologic predictors of ventricular tachyarrhythmia recurrence in patients with implantable cardioverter defibrillators.

Gillis AM, Sheldon RS, Wyse DG, Duff HJ, Cassidy MR, Mitchell LB.

J Cardiovasc Electrophysiol. 2003 May;14(5):492-8.

PMID:
12776866
Items per page

Supplemental Content

Write to the Help Desk